Mathias N - Search Results

1

pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: development of a canine model.

Zhou R, Moench P, Heran C, Lu X, Mathias N, Faria TN, Wall DA, Hussain MA, Smith RL, Sun D. Zhou R, et al. Among authors: mathias n. Pharm Res. 2005 Feb;22(2):188-92. doi: 10.1007/s11095-004-1185-3. Pharm Res. 2005. PMID: 15783065

2

Effect of delivery route on pulmonary response to oncostatin M.

Li HL, Mathias N, Timoszyk J, Stouffer B, Wall D. Li HL, et al. Among authors: mathias n. J Drug Target. 2002 Feb;10(1):55-62. doi: 10.1080/10611860290007531. J Drug Target. 2002. PMID: 11996087

3

The effect of anesthesia on the pharmacokinetics of sublingually administered verapamil in rabbits.

Moench PA, Heran CL, Stetsko PI, Mathias NR, Wall DA, Hussain MA, Smith RL. Moench PA, et al. J Pharm Sci. 2003 Sep;92(9):1735-8. doi: 10.1002/jps.10436. J Pharm Sci. 2003. PMID: 12949993 No abstract available.

4

A rabbit model for sublingual drug delivery: comparison with human pharmacokinetic studies of propranolol, verapamil and captopril.

Dali MM, Moench PA, Mathias NR, Stetsko PI, Heran CL, Smith RL. Dali MM, et al. J Pharm Sci. 2006 Jan;95(1):37-44. doi: 10.1002/jps.20312. J Pharm Sci. 2006. PMID: 16307454

5

Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers.

Li L, Mathias NR, Heran CL, Moench P, Wall DA, Smith RL. Li L, et al. J Pharm Sci. 2006 Feb;95(2):326-35. doi: 10.1002/jps.20541. J Pharm Sci. 2006. PMID: 16374869

6

Rat nasal lavage biomarkers to assess preclinical irritation potential of nasal drug formulations and excipients.

Mathias NR, Moench P, Heran C, Hussain MA, Smith RL. Mathias NR, et al. J Pharm Sci. 2009 Feb;98(2):495-502. doi: 10.1002/jps.21449. J Pharm Sci. 2009. PMID: 18506818

7

Discovery of (R)-4-(8-fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153): a potent antagonist of the human calcitonin gene-related peptide receptor for migraine with rapid and efficient intranasal exposure.

Degnan AP, Chaturvedula PV, Conway CM, Cook DA, Davis CD, Denton R, Han X, Macci R, Mathias NR, Moench P, Pin SS, Ren SX, Schartman R, Signor LJ, Thalody G, Widmann KA, Xu C, Macor JE, Dubowchik GM. Degnan AP, et al. J Med Chem. 2008 Aug 28;51(16):4858-61. doi: 10.1021/jm800546t. Epub 2008 Jul 30. J Med Chem. 2008. PMID: 18665579

8

Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117.

Qian F, Mathias N, Moench P, Chi C, Desikan S, Hussain M, Smith RL. Qian F, et al. Among authors: mathias n. Int J Pharm. 2009 Jan 21;366(1-2):218-20. doi: 10.1016/j.ijpharm.2008.10.020. Epub 2008 Nov 5. Int J Pharm. 2009. PMID: 19027057

9

Non-invasive systemic drug delivery: developability considerations for alternate routes of administration.

Mathias NR, Hussain MA. Mathias NR, et al. J Pharm Sci. 2010 Jan;99(1):1-20. doi: 10.1002/jps.21793. J Pharm Sci. 2010. PMID: 19499570 Review.

10

Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.

Qian F, Wang J, Hartley R, Tao J, Haddadin R, Mathias N, Hussain M. Qian F, et al. Among authors: mathias n. Pharm Res. 2012 Oct;29(10):2765-76. doi: 10.1007/s11095-012-0695-7. Pharm Res. 2012. PMID: 22315020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page